Neumora Therapeutics, Inc. · Brief

Next report

3 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26±30.0%▼−7.51%×0.25

quarterimplied−30%0+30%realized×

Q2 FY26±30.0%▼−7.51%×0.25

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 3

4disclosed supplier and customer ties in SEC filingsSEC filings

112managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

21managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

2 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

NMRA report session

No linked exposure.

Oct 23impliedImplied move: ±62.3% into Nov 5 earnings (Oct 23 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.